Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Egypt.
J Ethnopharmacol. 2024 Nov 15;334:118583. doi: 10.1016/j.jep.2024.118583. Epub 2024 Jul 14.
Liver and breast cancers are the most dominant cancer types with high occurrence rates. Artichoke (Cynara scolymus L.) has been reputed for its traditional use in alleviating many liver and gallbladder ailments beside its anticancer activity against various types of cancer cells.
To demonstrate detailed chemical matrices of the different plant parts and evaluate their cytotoxic activities aiming to unveil the relationship between these activities and the intrinsic metabolites using metabolomic studies, in-vitro experiments and network pharmacology.
Chemical profiling of extracts from the different plant parts (stems, leaves, bracts and receptacles) was performed using HPLC/QqQ/MS followed by unsupervised chemometric studies. In-vitro cytotoxic potentials of the extracts were evaluated on breast and liver cancer cell line then an OPLS study using linear regression was conducted. Consequently, a network pharmacology analysis on the most bioactive plant organ was applied.
Unsupervised chemometric analysis revealed that kaempferol-3-O-α-L-rhamnopyranoside-7-O-β-D-galacturonopyranoside, chrysoeriol-7-rutinoside and 1-caffeoylquinic acid were responsible for the segregation of the bract (CSB) segregated from the rest of the plant organs. Interestingly, CSB extract possessed the highest potential in-vitro cytotoxic activity against both liver and breast cancer cells (IC = 1.65 and 1.77 μg/mL). As expected, the aforementioned biomarkers were observed to be the discriminatory cytotoxic metabolites in the constructed supervised chemometric model. Network pharmacology analysis on CSB revealed 27 liver cancer-related metabolites of which, 1-caffeoylquinic acid was the most enriched one contributing to 13% of the total interactions. Furthermore, 38 target genes were involved, the most enriched of which were Aldo-keto reductase family 1 member B1 (AKR1B10) and interleukin-2 (IL-2). KEGG pathway analysis unveiled 23 significantly related pathways including metabolic pathways that possessed the lowest p-value (1.6E-5).
The findings demonstrated that CSB is a significant source of cytotoxic metabolites against breast cancer and liver cancer cell lines, hence, drawing attention to the pharmaceutical and medicinal value of this negligible plant organ and paving the route for insightful research into its exact pharmacological cytotoxic mechanisms.
肝癌和乳腺癌是最常见的癌症类型,发病率较高。朝鲜蓟(Cynara scolymus L.)因其在缓解肝胆疾病方面的传统用途而备受赞誉,此外,它还具有抗癌活性,可对抗多种类型的癌细胞。
展示不同植物部位的详细化学基质,并评估其细胞毒性活性,旨在利用代谢组学研究、体外实验和网络药理学揭示这些活性与内在代谢物之间的关系。
使用高效液相色谱/三重四极杆/质谱联用(HPLC/QqQ/MS)对来自不同植物部位(茎、叶、苞片和花托)的提取物进行化学分析,然后进行无监督化学计量学研究。评估提取物对乳腺癌和肝癌细胞系的体外细胞毒性潜力,然后使用线性回归进行 OPLS 研究。最后,对最具生物活性的植物器官进行网络药理学分析。
无监督化学计量学分析表明,山柰酚-3-O-α-L-鼠李吡喃糖苷-7-O-β-D-半乳糖吡喃糖苷、芹黄素-7-芸香糖苷和 1-咖啡酰奎宁酸负责将苞片(CSB)与其他植物器官分开。有趣的是,CSB 提取物对肝癌和乳腺癌细胞具有最高的体外细胞毒性活性(IC = 1.65 和 1.77 μg/mL)。正如预期的那样,上述生物标志物被观察到是构建的监督化学计量学模型中具有区分性的细胞毒性代谢物。对 CSB 的网络药理学分析显示,有 27 个与肝癌相关的代谢物,其中 1-咖啡酰奎宁酸是最丰富的一种,占总相互作用的 13%。此外,涉及 38 个靶基因,其中最丰富的是醛酮还原酶家族 1 成员 B1(AKR1B10)和白细胞介素-2(IL-2)。KEGG 途径分析显示,有 23 个显著相关的途径,包括代谢途径,其 p 值最低(1.6E-5)。
研究结果表明,CSB 是一种具有抗乳腺癌和肝癌细胞系细胞毒性活性的重要代谢物来源,因此,引起了人们对这种微不足道的植物器官的药用和药用价值的关注,并为深入研究其确切的药理学细胞毒性机制铺平了道路。